Performance Improvement 1999. Infectious Disease

02/01/1999

TITLE: Evaluation of Group B Strep Guidelines

ABSTRACT: Group B Streptococcus (GBS) is the leading cause of bacterial infection in newborns in the United States. This project will assess a number of issues that affect successful management of GBS disease in the United States.

AGENCY SPONSOR: National Center for Infectious Diseases

FEDERAL CONTACT: Anne Schuchat, M.D.

PHONE NUMBER: 404-639-2215

PIC ID: 6333

PERFORMER ORGANIZATION: American Association of Health Plans Washington, D.C.

PROJECTED DATE OF COMPLETION: 1/29/99
 

TITLE: Evaluation of Implementation/Impact of VRE Guidelines

ABSTRACT: In response to the recent emergence of vancomycin resistance among enterococci (VRE), the Centers for Disease Control and Prevention (CDC) published "Recommendations for Preventing the Spread of Vancomycin Resistance." The purposes of this study are to determine the efficacy of different types of VRE control measures and their costs, and to develop a community-wide facility approach to VRE control.

AGENCY SPONSOR: National Center for Infectious Diseases

FEDERAL CONTACT: Jerome Tokars, M.D., MPH

PHONE NUMBER: 404-639-6418

PIC ID: 6703

PERFORMER ORGANIZATION: Health Care Financing Administration Baltimore, MD

PROJECTED DATE OF COMPLETION: 8/7/99